Raffles Medical Group

The private hospital group will see downside risks from lower TCF contributions. 

Singapore’s private hospital group seeks to acquire a majority interest.

The company attributed the increase to the return of foreign patients.

Elective surgery revival will benefit the hospital group.

Its target price was at $1.60.

Patient numbers had increased on the back of recovering medical tourism.

This is on the back of expected lower revenue from the hospital's COVID-19 services.

The group’s profits after tax ballooned by as much as 138.4%.

On back of higher patient load, clinic network expansion.

They rely on their group practice model.

On back of increased staff expenses.

It’s a year of integration and expansion for the firm.

There were fewer foreign patients in Q3.

Raffles Medical Group is looking to bounce by breaking into China this year. The Singapore-based health care provider, which operates dozens of medical clinics and laboratories as well as the Raffles Hospital, encountered a slight growth hiccup but it hopes to re-ignite its growth engine through an aggressive China expansion strategy. RFMD announced its collaboration with Shanghai Lujiazui to build a 300-bed hospital in Pudong, the bustling financial district in Shanghai, teeming with wealthy expats and a local population of more than 5 million. Raffles Medical has also agreed to work with China Merchant Group for a similar 200-bed hospital venture in Shenzhen, one of the country’s most successful Special Economic Zones situated just north of Hong Kong. Management is even considering building hospitals in the capital Beijing.